Karolinska Development AB Overview
Karolinska Development AB is a venture capital firm specializing in early-stage investments in the life sciences sector. Founded in 2003 and headquartered in Solna, Sweden, the company focuses on identifying and nurturing medical innovations, particularly from the Nordic region, and advancing them into commercial products. It manages a portfolio of companies targeting innovative treatments for severe diseases, leveraging access to cutting-edge medical research from institutions like the Karolinska Institutet. The firm typically leads investment rounds and maintains active ownership in its portfolio companies.
Is Karolinska Development AB the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Karolinska Development AB, along with a list of other relevant VCs, is available on Hopohopo.io.
Karolinska Development AB
Investment focus
Invest in
- Nordics
Product type
- Hardware
- Drugs / Pharma
Industries / verticals
- BioTech & Life Sciences
- MedTech & Devices
- PharmaTech
Stages
Pre-seed, Seed
First ticket size
SEK 100,000 - SEK 1,500,000
How to approach funds like Karolinska Development AB
When approaching Karolinska Development, founders should highlight robust clinical validation and a clear path to significant medical impact, as the firm values transformative science with strong translational potential. Demonstrate how your technology addresses unmet clinical needs and can scale from research to commercial application, especially if leveraging academic partnerships. Articulate your strategy for regulatory milestones and early proof-of-concept, as their team is hands-on and expects clear, data-driven progress markers.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
